Filtros : "FÁRMACOS" "Financiamento Conicet, Argentina" Removidos: "Landgraf, Mariza" "aw" "ku" "Grego" Limpar

Filtros



Refine with date range


  • Source: International Journal of Pharmaceutics. Unidade: IFSC

    Subjects: ANTI-HISTAMÍNICOS H2, CRISTALOGRAFIA, FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RUSSO, Marcos Guillermo et al. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution. International Journal of Pharmaceutics, v. 642, p. 123053-1-123053-10 + supplementary material, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2023.123053. Acesso em: 02 ago. 2024.
    • APA

      Russo, M. G., Brusau, E. V., Ellena, J., & Narda, G. E. (2023). Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution. International Journal of Pharmaceutics, 642, 123053-1-123053-10 + supplementary material. doi:10.1016/j.ijpharm.2023.123053
    • NLM

      Russo MG, Brusau EV, Ellena J, Narda GE. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution [Internet]. International Journal of Pharmaceutics. 2023 ; 642 123053-1-123053-10 + supplementary material.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123053
    • Vancouver

      Russo MG, Brusau EV, Ellena J, Narda GE. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution [Internet]. International Journal of Pharmaceutics. 2023 ; 642 123053-1-123053-10 + supplementary material.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.123053
  • Source: Inorganic Chemistry Frontiers. Unidade: IFSC

    Subjects: ANTINEOPLÁSICOS, NEOPLASIAS, FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LEVÍN, Pedro et al. Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug. Inorganic Chemistry Frontiers, v. 8, n. 13, p. 3238-3252, 2021Tradução . . Disponível em: https://doi.org/10.1039/d1qi00233c. Acesso em: 02 ago. 2024.
    • APA

      Levín, P., Ruiz, M. C., Romo, A. I. B., Nascimento, O. R., Virgilio, A. L. D., Oliver, A. G., et al. (2021). Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug. Inorganic Chemistry Frontiers, 8( 13), 3238-3252. doi:10.1039/d1qi00233c
    • NLM

      Levín P, Ruiz MC, Romo AIB, Nascimento OR, Virgilio ALD, Oliver AG, Ayala AP, Diógenes ICN, León IE, Lemus L. Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug [Internet]. Inorganic Chemistry Frontiers. 2021 ; 8( 13): 3238-3252.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1039/d1qi00233c
    • Vancouver

      Levín P, Ruiz MC, Romo AIB, Nascimento OR, Virgilio ALD, Oliver AG, Ayala AP, Diógenes ICN, León IE, Lemus L. Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug [Internet]. Inorganic Chemistry Frontiers. 2021 ; 8( 13): 3238-3252.[citado 2024 ago. 02 ] Available from: https://doi.org/10.1039/d1qi00233c

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024